PROJECT 10:
Host:
Department of Medical and Molecular Genetics, King‘s College London

PI:
Gillian Bates
Fellow:
Raffaella Tulino

Huntington's disease (HD) is a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline and psychiatric problems. It is caused by a CAG repeat expansion in Exon 1 of the huntingtin (HTT) gene which translates to a polyglutamine tract close to the N-terminus of the huntingtin protein (HTT). Symptoms progress over a period of 15-20 years until death and disease modifying treatments do not currently exist.
The main focus of our work uses mouse models of HD to
- Better understand the molecular pathogenesis of HD
- Validate therapeutic targets
- Participate in the preclinical development of therapeutic interventions